SCHEMBL5961364

SCHEMBL5961364

Nc1ncnc2c1ncn2[C@H]1O[C@@H](COCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1OCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 2/20 0.64
▸ HTR1A P08908 1/20 0.56
▸ AHCY P23526 2/20 0.54
▸ HSPA5 P11021 1/20 0.51
▸ ADORA1 P30542 3/20 0.51
▸ P2RY12 Q9H244 2/20 0.50
▸ P2RX3 P56373 1/20 0.50
▸ P2RX4 Q99571 1/20 0.50
▸ P2RX2 Q9UBL9 1/20 0.50
▸ NT5E P21589 1/20 0.50
▸ DOT1L Q8TEK3 3/20 0.49
▸ P2RY2 P41231 1/20 0.49
▸ P2RY1 P47900 1/20 0.49
▸ BCHE P06276 1/20 0.48
▸ SLC29A1 Q99808 2/20 0.48
▸ DPP4 P27487 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ SLC28A1 O00337 1/20 0.47
▸ MAP3K7 O43318 1/20 0.47
▸ SLC28A2 O43868 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11427985 1.00 PDE2A (0.64) PDE2AHTR1AAHCYHSPA5ADORA1
SCHEMBL14429057 0.94 PDE2A (0.59) PDE2AHTR1AAHCYHSPA5ADORA1
SCHEMBL14429257 0.92 PDE2A (0.59) PDE2AAHCYHSPA5ADORA1P2RY12
SCHEMBL14429024 0.92 PDE2A (0.71) PDE2AHTR1AAHCYHSPA5ADORA1
SCHEMBL14428965 0.92 PDE2A (0.59) PDE2AAHCYHSPA5ADORA1P2RY12
SCHEMBL20096659 0.89 AHCY (0.55) PDE2AAHCYADORA1P2RY12NT5E
SCHEMBL8764444 0.87 PDE2A (0.70) PDE2AHTR1AADORA1NT5EBCHE
SCHEMBL750344 0.87 PDE2A (0.72) PDE2AHTR1AADORA1NT5EBCHE
SCHEMBL622588 0.85 ADORA1 (0.69) PDE2AAHCYHSPA5ADORA1DOT1L
SCHEMBL7906337 0.85 HSPA5 (0.62) PDE2AAHCYHSPA5ADORA1NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1283211-B1 L-Nucleosides for the treatment of hepatitis B-virus and Epstein-barr virus UNIV GEORGIA RES FOUND (US) 2006-06-07 — — EP disclosed
EP-0748330-B1 L-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B-VIRUS AND EPSTEIN-BAR VIRUS UNIV GEORGIA RES FOUND (US) 2003-04-02 — — EP disclosed
EP-1283211-A2 L-Nucleosides for the treatment of hepatitis B-virus and Epstein-barr virus THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2003-02-12 — — EP disclosed
US-5808040-A VIRICIDES YALE UNIVERSITY (US) 1998-09-15 — — US disclosed
US-5753789-A Oligonucleotides containing L-nucleosides YALE UNIVERSITY (US) 1998-05-19 — — US disclosed
US-5567688-A ADMINISTERING SPECIFIED ENANTIOMORPH TO HUMAN INFECTED WITH HEPATITIS B VIRUS UNIV. OF GA RESEARCH FOUNDATION (US) 1996-10-22 — — US disclosed
US-5565438-A L-nucleosides for the treatment of epstein-bar virus UNIVERSITY OF GA RESEARCH FOUNDATION (US) 1996-10-15 — — US disclosed
Send feedback